SCHEMBL4437388

SCHEMBL4437388

C[C@H]1OC(=O)CC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437392 1.00
SCHEMBL14288621 1.00
SCHEMBL4303308 1.00
SCHEMBL10339618 0.78 SMN1; SMN2 (0.40)
SCHEMBL10339617 0.78 SMN1; SMN2 (0.40)
SCHEMBL14275669 0.76
Hydrochloric Acid SCHEMBL9432885 0.76 SMN1; SMN2 (0.39)
Hydrochloric Acid SCHEMBL10979979 0.76 SMN1; SMN2 (0.39)
Hydrochloric Acid SCHEMBL11067541 0.76 SMN1; SMN2 (0.39)
Hydrochloric Acid SCHEMBL11235531 0.76 SMN1; SMN2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090305995-A1 AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR NOVARTIS AG (CH) 2009-12-10 US disclosed
EP-1814900-A1 AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR Novartis AG (CH) 2007-08-08 EP disclosed
WO-2006053700-A1 AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR NOVARTIS AG (CH) 2006-05-26 WO disclosed